The story of Martin Shkreli, the rich white man America loves to hate, is getting more and more curious.
Advertisement
Four Turkish soldiers injured in Islamic State attack
Citing threats from IS, Turkey recently sent an unspecified number of reinforcements to the camp, sparking an uproar in Baghdad. Large territories of Iraq and Syria have been occupied by Daesh, a terrorist group outlawed in Russian Federation .
If you happen to follow Martin Shkreli-the former CEO of a pharmaceutical company who’s now facing a slew of charges for USA securities fraud-on Twitter, you may have noticed some unusual changes in his profile over the weekend.
Trump’s idea of a Muslim ban has US legal experts divided
Maybe they just want to be on his “like” list so they can keep abreast of his latest antics. Trump said he didn’t do it for the polls, so he doesn’t care what the polls say.
Shkreli has been held up as the poster boy of USA capitalism run amok for what he has done at Turing Pharmaceuticals, a private company where he was chief executive. He also resigned from the company’s board of directors.
Listen To The Beatles On Your Streaming Service Beginning Christmas Eve
This will include all of their classic studio albums plus compilations like Past Masters , 1, The Red Album and The Blue Album. Well, not really magical, but it will actually lead you to your favorite Beatles song or album.
While making the announcement in a statement, the company did not say whether it was looking for an interim CEO or permanent CEO to replace Shkreli. Trading in KaloBios shares was halted that day and has yet to resume.
In an interview with the Wall Street Journal, he said that the government was “trying to find anything [it] could to stop him”.
The KaloBios ouster marks the latest setback for the 32-year-old healthcare industry entrepreneur who has drawn widespread criticism for imposing steep price hikes in the cost of drugs controlled by his companies.
Shkreli has pleaded not guilty to the federal charges, and faces up to 20 years in prison if convicted of the securities and conspiracy charges.
Shkreli, founder and CEO of Turing, rose to infamy earlier this year after he, bought rights to toxoplasmosis drug Daraprim and promptly raised the price from $13.50 a tablet to $750. He resigned as its CEO on Friday. “It seemed to me like it would be fun to experiment with”, Shkreli said in the interview.
After Shkreli disclosed in November that he had taken a large stake in the struggling drug firm, KaloBios shares soared.
Advertisement
Shkreli was charged on Thursday with securities fraud, securities fraud conspiracy and wire fraud conspiracy related to his management of hedge fund MSMB Capital Management and biopharmaceutical company Retrophin Inc (RTRX.O). On Monday, he and his attorneys finally regained control of the recently arrested ex-pharmaceutical C.E.O.’s Twitter account, after it was hacked and began sending, without context, messages all-too similar to things Shkreli might actually tweet.
